Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Augmedix, Inc. (AUGX)
|
Add to portfolio |
|
|
|
| Price: |
$3.19
| | Metrics |
| OS: |
40.8
|
M
| |
-535
|
% ROE
|
| Market cap: |
$130
|
M
| |
-82
|
% ROIC
|
|
Net debt:
|
$37.8
|
M
| |
|
|
|
EV:
|
$168
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($20.2)
|
M
| |
|
|
|
EBIT
|
($20.9)
|
M
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 30.9 | 22.2 | 16.5 | 14.1 | 10.8 |
| Revenue growth | 39.6% | 34.5% | 16.8% | 30.4% | |
| Cost of goods sold | 17.0 | 12.2 | 9.7 | 9.4 | 10.0 |
| Gross profit | 14.0 | 10.0 | 6.8 | 4.7 | 0.8 |
| Gross margin | 45.1% | 45.1% | 41.2% | 33.2% | 7.3% |
| Sales and marketing | 9.3 | 7.5 | 4.4 | 3.6 | 3.6 |
| Research and development | 10.1 | 6.7 | 4.5 | 7.0 | 7.0 |
| General and administrative | 16.9 | 13.8 | 11.6 | 10.9 | 13.2 |
| EBIT | -22.4 | -17.9 | -13.7 | -16.7 | -22.9 |
| EBIT margin | -72.3% | -80.9% | -83.1% | -118.7% | -211.9% |
| Pre-tax income | -24.4 | -17.9 | -15.6 | -18.5 | -24.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -24.4 | -17.9 | -15.6 | -18.5 | -24.2 |
| Net margin | -79.0% | -80.5% | -94.7% | -131.1% | -223.4% |
| |
| Diluted EPS | | ($0.62) | ($2.17) | ($0.92) | ($20.32) |
| Shares outstanding (diluted) | | 28.9 | 7.2 | 20.1 | 1.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|